Oxford Nanopore Demonstrates Label-Free Method for DNA Sequencing



Loading...

By Kevin Davies

February 22, 2009 | In an important paper published online this week in the journal Nature Nanotechnology, scientists at Oxford Nanopore Technologies present the first proof-of-principle of their label-free next-generation sequencing system.

The paper*, by James Clarke and colleagues, shows that an engineered nanopore complex can discriminate between the four bases of DNA (A, C, T and G) with remarkable specificity, and can even identify methylated C residues (“the fifth base”) for good measure. The senior author of the report is Hagan Bayley, Oxford University chemistry professor and co-founder of Oxford Nanopore, who has been leading research into nanopores as detectors for sequencing and other applications for over a decade.

There is immense appeal in a DNA sequencing technology that dispenses with fluorescently tagged molecules, CCD cameras, and expensive microscopes, and thus has the makings of an affordable, real-time, label-free sequencing system. The Oxford Nanopore Nature Nanotechnology paper does not go so far as describing a prototype device or even reading the sequence of a DNA molecule. But it does is show that Oxford scientists have engineered the alpha-hemolysin nanopore to the point that it can efficiently discriminate between the four natural bases of DNA at speeds suitable for high-throughput applications.

Oxford Figure
Nanopores have shown considerable potential for DNA sequencing for more than a decade, but single-stranded DNA molecules slide through the nanopore much too quickly to recognize individual bases. Taking a different tack, Bayley’s group showed a few years ago that it could partially identify individual bases as they dropped through a nanopore by the degree to which they impeded the current flowing across the membrane housing the nanopore.

Building upon that work, Clarke and coworkers genetically engineered the alpha-hemolysin to find the best location to covalently attach a molecule of cyclodextrin -- a kind of washer that sits in the middle of the pore. The result is a molecular machine – a ring-like assembly of seven subunits, one of which has been modified to clamp the cyclodextrin -- that recognizes virtually every base passing through the pore.

By altering variables such as salt concentration, pH and temperature, Clarke and colleagues found conditions that allowed them to resolve the four bases to an accuracy of about 99.8%. The slight difference in size of the four bases results in a discrete blockage of the pore, which is read as a reproducible dip in the applied current from a baseline of around 60 picoamps to anywhere from 20-40 picoamps. In the current system, bases can be identified as they flow through the nanopore at a rate of about 25 per second.

Next Steps

Clarke and colleagues conclude that they have “solve[d] the key technical problems required for real-time, high-resolution nucleoside monophosphate detection.” They go on to state: “These advances represent the realization of a complete nanopore base detector, which, when combined with a compatible exonuclease DNA processing system, will provide the basis of a complete nanopore sequencer.”

That indeed is the next crucial step for Oxford Nanopore – to couple an exonuclease enzyme to the nanopore so that single bases are cleaved off a template DNA strand and their identity read off instantaneously as they funnel through the nanopore. Clark and colleagues conclude the Nature Nanotechnology paper by showing that the nanopore does indeed work in salt conditions favoring exonuclease activity and can detect bases cleaved off DNA strands in solution by the enzyme.

Oxford Nanopore was founded in 2005 and is located on the outskirts of Oxford, UK. Last month, the company announced an $18-million sales and distribution deal with Illumina for its exonuclease-based sequencing technology.

Editor’s note: Oxford Nanopore’s James Clarke will be presenting a poster on this work at CHI’s Next-Generation Sequencing conference, March 17-19, in San Diego.

*FURTHER READING: Clarke, J. et al. “Continuous base identification for single-molecule nanopore DNA sequencing.” Nature Nanotech. 2009.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Quantum
StorNext 4.0: Technical Product Brief
Sponsored by Quantum

 
Proven in the world’s most data intensive industries, Quantum StorNext is a scalable, high-performance file system which allows data sharing across Linux, Mac, Unix, and Windows operating systems and manages data in enterprise storage environments. In this Technical Brief you'll learn:

  • How a high-performing file system can accelerate your business
  • How to simplify your data management
  • How a tiered storage approach can save you money


SURETY-IP_WPx108
Protect Your Scientific Intellectual Property: Proof of Lab Informatics Data Authenticity is Your Best Legal Defense
Sponsored by Surety, LLC

As a bio-technology or life sciences organization, your formulas, treatments and research and discoveries are the “lifeblood” of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing IP ownership, revenue and consequently your business if you can't prove time-of-creation and data authenticity. Learn how you can implement simple, cost-effective and automated controls to protect your scientific intellectual property. Consider:

  • IP protection requirements in bio-pharma and other science-oriented industries can extend out 20, 30, 40 or more years
  • Most electronic lab management solutions include generic authenticity controls, so how "legally defensible" is yours?
  • Only standards-compliant, independent controls can future-proof your approach to long-term IP integrity protection and authenticity.
  • Learn more - get the free whitepaper now


BlueArc_WP_DataMigration.jpg
The Key to Life Sciences Data Management: Transparent Migration
Sponsored by BlueArc

Life sciences organizations face new data management challenges as the volume of research data grows and more data is kept online for longer times. Read this paper to learn about:

  • The benefits of transparent data migration (TDM)
  • How TDM technologies can simplify data management.
  • How using TDM can help increase storage utilization, improve computational workflow performance, and optimize the use of storage resources.


Life Science Webcasts & Podcasts

adobe_i3_btn_webinarNext-Generation Clinical Trial and Data Management Applications
Sponsored by Adobe

This webinar introduces i3Cube - a web-based, fully integrated, clinical trial and data management system built on Adobe’s LiveCycle® Enterprise Suite.  I3 cube provides end-to-end automation that delivers unprecedented visibility into information that sponsors need to accelerate the study process and complete trials efficiently. Viewers will learn more about:

  • Creating faster and more efficient trial processes
  • Reducing investigator burden 
  • Real-time sponsor transparency into study information
  • Enterprise solutions based on Adobe LiveCycle® ES utilizing cross-platform clients of Reader, Flash and AIR

    Download now.



More Podcasts

Job Openings

Employers -- Don't miss this opportunity to reach well-qualified life science candidates.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.